247 related articles for article (PubMed ID: 25581824)
1. Effect of genetic deletion or pharmacological antagonism of tumor necrosis factor alpha on colitis-associated carcinogenesis in mice.
Craven B; Zaric V; Martin A; Mureau C; Egan LJ
Inflamm Bowel Dis; 2015 Mar; 21(3):485-95. PubMed ID: 25581824
[TBL] [Abstract][Full Text] [Related]
2. Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.
Pouyet L; Roisin-Bouffay C; Clément A; Millet V; Garcia S; Chasson L; Issaly N; Rostan A; Hofman P; Naquet P; Galland F
Inflamm Bowel Dis; 2010 Jan; 16(1):96-104. PubMed ID: 19572375
[TBL] [Abstract][Full Text] [Related]
3. Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6/STAT3 signaling pathway.
Yang X; Zhang F; Wang Y; Cai M; Wang Q; Guo Q; Li Z; Hu R
Inflamm Bowel Dis; 2013 Aug; 19(9):1990-2000. PubMed ID: 23823704
[TBL] [Abstract][Full Text] [Related]
4. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.
Popivanova BK; Kitamura K; Wu Y; Kondo T; Kagaya T; Kaneko S; Oshima M; Fujii C; Mukaida N
J Clin Invest; 2008 Feb; 118(2):560-70. PubMed ID: 18219394
[TBL] [Abstract][Full Text] [Related]
5. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
Kim SW; Kim HM; Yang KM; Kim SA; Kim SK; An MJ; Park JJ; Lee SK; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2010 Sep; 16(9):1514-25. PubMed ID: 20310012
[TBL] [Abstract][Full Text] [Related]
6. RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer.
Long TM; Chakrabarti A; Ezelle HJ; Brennan-Laun SE; Raufman JP; Polyakova I; Silverman RH; Hassel BA
Inflamm Bowel Dis; 2013 May; 19(6):1295-305. PubMed ID: 23567782
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis.
Vendramini-Costa DB; Francescone R; Posocco D; Hou V; Dmitrieva O; Hensley H; de Carvalho JE; Pilli RA; Grivennikov SI
Carcinogenesis; 2017 Jan; 38(1):51-63. PubMed ID: 27797827
[TBL] [Abstract][Full Text] [Related]
8. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice.
Naito Y; Takagi T; Handa O; Ishikawa T; Nakagawa S; Yamaguchi T; Yoshida N; Minami M; Kita M; Imanishi J; Yoshikawa T
J Gastroenterol Hepatol; 2003 May; 18(5):560-9. PubMed ID: 12702049
[TBL] [Abstract][Full Text] [Related]
9. Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice.
Klimesova K; Kverka M; Zakostelska Z; Hudcovic T; Hrncir T; Stepankova R; Rossmann P; Ridl J; Kostovcik M; Mrazek J; Kopecny J; Kobayashi KS; Tlaskalova-Hogenova H
Inflamm Bowel Dis; 2013 May; 19(6):1266-77. PubMed ID: 23567778
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effect of dietary glutamine on colitis-associated colon tumorigenesis in mice.
Tian Y; Wang K; Wang Z; Li N; Ji G
Carcinogenesis; 2013 Jul; 34(7):1593-600. PubMed ID: 23471883
[TBL] [Abstract][Full Text] [Related]
11. 3,3'-diindolylmethane attenuates colonic inflammation and tumorigenesis in mice.
Kim YH; Kwon HS; Kim DH; Shin EK; Kang YH; Park JH; Shin HK; Kim JK
Inflamm Bowel Dis; 2009 Aug; 15(8):1164-73. PubMed ID: 19334074
[TBL] [Abstract][Full Text] [Related]
12. Sonic hedgehog inhibitors prevent colitis-associated cancer via orchestrated mechanisms of IL-6/gp130 inhibition, 15-PGDH induction, Bcl-2 abrogation, and tumorsphere inhibition.
Kangwan N; Kim YJ; Han YM; Jeong M; Park JM; Go EJ; Hahm KB
Oncotarget; 2016 Feb; 7(7):7667-82. PubMed ID: 26716648
[TBL] [Abstract][Full Text] [Related]
13. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines.
Yasui Y; Hosokawa M; Mikami N; Miyashita K; Tanaka T
Chem Biol Interact; 2011 Aug; 193(1):79-87. PubMed ID: 21621527
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer.
Koh SJ; Kim JM; Kim IK; Ko SH; Kim JS
J Gastroenterol Hepatol; 2014 Mar; 29(3):502-10. PubMed ID: 24716225
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis.
Onizawa M; Nagaishi T; Kanai T; Nagano K; Oshima S; Nemoto Y; Yoshioka A; Totsuka T; Okamoto R; Nakamura T; Sakamoto N; Tsuchiya K; Aoki K; Ohya K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G850-9. PubMed ID: 19179628
[TBL] [Abstract][Full Text] [Related]
16. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
17. NF-κB1, NF-κB2 and c-Rel differentially regulate susceptibility to colitis-associated adenoma development in C57BL/6 mice.
Burkitt MD; Hanedi AF; Duckworth CA; Williams JM; Tang JM; O'Reilly LA; Putoczki TL; Gerondakis S; Dimaline R; Caamano JH; Pritchard DM
J Pathol; 2015 Jul; 236(3):326-36. PubMed ID: 25727407
[TBL] [Abstract][Full Text] [Related]
18. alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T; Kotake Y
Antioxid Redox Signal; 2002 Feb; 4(1):195-206. PubMed ID: 11970853
[TBL] [Abstract][Full Text] [Related]
19. Nuclear adenomatous polyposis coli suppresses colitis-associated tumorigenesis in mice.
Zeineldin M; Miller MA; Sullivan R; Neufeld KL
Carcinogenesis; 2014 Aug; 35(8):1881-90. PubMed ID: 24894865
[TBL] [Abstract][Full Text] [Related]
20. AVX-470: a novel oral anti-TNF antibody with therapeutic potential in inflammatory bowel disease.
Bhol KC; Tracey DE; Lemos BR; Lyng GD; Erlich EC; Keane DM; Quesenberry MS; Holdorf AD; Schlehuber LD; Clark SA; Fox BS
Inflamm Bowel Dis; 2013 Oct; 19(11):2273-81. PubMed ID: 23949620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
